title: FDA panel backs interleukin-2.
authors.forename: B J
authors.initials: BJ
authors.lastname: Culliton
mesh_terms: D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D013727:Terminal Care; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D007376:Interleukin-2